Does Neurocrine, The No. 1 Biotech Stock, Have The Next Ketamine On Its Hands?
Investor's Business DailyTop-notch biotech stock Neurocrine surged Tuesday after analysts suggested the company’s depression treatment could rival ketamine.
The post Does Neurocrine, The No. 1 Biotech Stock, Have The Next Ketamine On Its Hands? appeared first on Investor'…